Table 41 (abstract P116). Clinical features of the most prevalent subtypes
From: Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part one
Circumscribed | Mixed | Linear | Generalized | CDS | Total | P value | |
|---|---|---|---|---|---|---|---|
Frequency (%) | 29 | 28 | 12 | 10 | 7 | 86 | |
Mean age at diagnosis(years) | 8,0 | 6,2 | 8,1 | 7,3 | 5,9 | 6,9 | 0,255 |
Disease duration at diagnosis | 11,9 | 22,6 | 13,6 | 12,6 | 23,9 | 16,8 | 0,623 |
Extra cutaneous involvement n(%) | 2(6,9) | 7(25) | 3(25) | 2(20) | 3(42,9) | 17(19,8) | 0,194 |
Autoimmune associated disease n(%) | 4(3,8) | 4(14,3) | 2(16,7) | 1(10) | 0(0) | 11(12,8) | 0,854 |
Unsightly effects n(%) | 25(86,2) | 25(89,3) | 12(100) | 9(90) | 7(100) | 78(90,7) | 0,607 |
Joint functional involvement n(%) | 0(0) | 15(53,6) | 6(50) | 6(60) | 0(0) | 27(31,4) | 0,000 |
Growth disturbances n(%) | 3(10,3) | 17(60,7) | 7(58,3) | 2(20) | 5(71,4) | 34(39,5) | 0,000 |
2 or more complications n(%) | 3(10,3) | 19(67,9) | 7(58,3) | 7(70) | 5(71,4) | 41(47,7) | 0,001 |